Canada Pension Plan Investment Board
TAK icon

Canada Pension Plan Investment Board’s Takeda Pharmaceutical TAK Stock Holding History

Canada Pension Plan Investment Board’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10
Closed – – 1556
2021
Q4 		$0 Hold
10
– – ﹤0.01% 1612
2021
Q3 		$0 Hold
10
– – ﹤0.01% 1468
2021
Q2 		$0 Sell
10
-57,780
-100% -$984K ﹤0.01% 1351
2021
Q1 		$1.05M Sell
57,790
-302,600
-84% -$5.44M ﹤0.01% 991
2020
Q4 		$6.56M Buy
360,390
+126,500
+54% +$2.22M 0.01% 569
2020
Q3 		$4.17M Hold
233,890
– – 0.01% 531
2020
Q2 		$4.19M Buy
+233,890
New +$4.2M 0.01% 566
2019
Q2 		– Sell
-71,316
Closed -$1.45M – 1466
2019
Q1 		$1.45M Buy
+71,316
New +$1.44M ﹤0.01% 1051

Other funds holding TAK

PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Canada Pension Plan Investment Board's TAK Position: Q1 2022 in Review

Canada Pension Plan Investment Board sold out of Takeda Pharmaceutical (TAK) in Q1 2022, closing a stake of 10 shares.

Canada Pension Plan Investment Board first reported a position in TAK in Q1 2019 and held it in 8 quarters. The position peaked at $6.56M in Q4 2020. 287 funds tracked by Wall St. Rank hold TAK as of Q1 2022.

  • Canada Pension Plan Investment Board reported no remaining Takeda Pharmaceutical position as of Q1 2022 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 10 Takeda Pharmaceutical shares in Q1 2022.
  • Canada Pension Plan Investment Board first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 8 quarters.
  • Canada Pension Plan Investment Board's Takeda Pharmaceutical position peaked at $6.56M in Q4 2020.
  • 287 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2022.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2022, filed 13 May 2022.